ArticleCase reports in endocrinology2026
Severe Osteoporosis in a Young Woman With Type 1 Diabetes and Pancreatic Exocrine Insufficiency.
Article in Case reports in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Severe Osteoporosis in a Young Woman With Type 1 Diabetes and Pancreatic Exocrine Insufficiency.Case reports in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with type 1 diabetes mellitus (T1DM) are at increased risk of osteoporosis; however, contributing secondary factors may be under-recognised. We report a case of a 29-year-old woman with a 10-year history of suboptimally controlled T1DM (HbA1c 10.1%-14.7%) who presented with an atraumatic tibial fracture and vertebral compression fractures. She had a history of significant weight loss (nadir 37 kg) and chronic malabsorption. Investigations demonstrated severe pancreatic exocrine insufficiency (PEI; faecal elastase 42 μg/g), vitamin D deficiency (25 nmol/L), and secondary hyperparathyroidism (PTH 10.8 pmol/L). Dual-energy X-ray absorptiometry revealed reduced bone mineral density at the total hip (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.